… from their use about therapeutic effects and adverse events. … the ones that require iv antibiotic
therapy and/ or hospitalization… Therapeutic efficacy of multiple intravenous infusions of anti-…

… are associated with lower treatment efficacy. The enhanced incidence … Tumor necrosis factor-α
is a pleiotropic, proinflammatory … However, it is immunogenic in many patients, resulting in …

… therapy, treated for 3 days with 1,000 mg IV … (IFN)–γ, and tumor necrosis factor (TNF)–α
using a commercial multiplexed … 20 The rapid onset of alemtuzumab treatment effects can be …

… Initially: given at the clinic or at an infusion centre as an IV at … , is now available in many
countries for use in rheumatoid … of anti TNF-α treatment and the most common TNF-α inhibitor …

… After treatment failure with a tumor necrosis factor inhibitor (TNFi), patients with rheumatoid
… This study compared treatment patterns and treatment effectiveness between TNFi cyclers …

… in selecting therapy and developing combination therapies. … approvals in several cancer
types—eg, bladder cancer, non-… GITR=glucocorticoid-induced tumour necrosis factor receptor …

… The study drug infliximab was infused intravenously in a … potentially associated with treatment
effectiveness. Some factors … of infusion reactions and the discontinuation of the treatment. …

… via radial and right internal jugular vein, respectively. Heparin, … tried to show the relation of
multiple factors (after operation) … infusions, they are presumably exposed to higher levels of …

… , such as CD40 (tumour necrosis factor receptor; TNFR), CD80 (… to assess the safety of
intravenous (iv) infusions of eASCs in … treated with Cx611, as treatment effect waned or fluctuated (…

… The most common route of administration is IV, because most … lymphodepletion treatment
prior to modified T-cell infusion to … can be harnessed to maximize therapeutic effects. …